Papulo-pustular eruption during cetuximab treatment.
Satta
R
R
Cuccuru
M A
MA
Pirodda
C
C
Cottoni
F
F
D017486:Acneiform Eruptions / Q000139:chemically induced*; D000230:Adenocarcinoma / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001415:Back; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000276:immunology; D005148:Facial Dermatoses / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000276:immunology; D013909:Thorax
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; C512478:EGFR protein, human; D066246:ErbB Receptors; D000068818:Cetuximab